Herceptin (Trastuzumab) is a targeted therapy used to treat HER2-positive breast cancer. It works by binding to the HER2 receptors on the surface of cancer cells, blocking the signals that promote cell growth and division. This helps to slow down or stop the growth of the cancer, improving patient outcomes and reducing the risk of recurrence.